ducovest

EL4I:XETRA:XETRA-Deka MSCI USA LC UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 388.4

Change

0.00 (0.00)%

Market Cap

USD 0.10B

Volume

1.18K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: EUR

Country : Germany

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

N/A

 USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

N/A

 USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

N/A

 USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

N/A

 USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

N/A

 USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

N/A

 USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

N/A

 USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

N/A

 USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

N/A

 USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

N/A

 USD 80.38B

ETFs Containing EL4I:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 33.17% 90% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.17% 90% A- 88% B+
Trailing 12 Months  
Capital Gain 33.17% 90% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.17% 90% A- 88% B+
Trailing 5 Years  
Capital Gain 103.95% 95% A 93% A
Dividend Return 0.37% N/A F 1% F
Total Return 104.32% 95% A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 16.52% 87% B+ 84% B
Dividend Return 16.52% 87% B+ 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.32% 35% F 47% F
Risk Adjusted Return 107.81% 95% A 95% A
Market Capitalization 0.10B 33% F 29% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.